These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 30396382)

  • 1. Levetiracetam inhibits endocytosis and augments short-term depression.
    Pharmazie; 2018 Nov; 73(11):643-646. PubMed ID: 30396382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brivaracetam augments short-term depression and slows vesicle recycling.
    Yang X; Bognar J; He T; Mohammed M; Niespodziany I; Wolff C; Esguerra M; Rothman SM; Dubinsky JM
    Epilepsia; 2015 Dec; 56(12):1899-909. PubMed ID: 26515103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new mechanism for antiepileptic drug action: vesicular entry may mediate the effects of levetiracetam.
    Meehan AL; Yang X; McAdams BD; Yuan L; Rothman SM
    J Neurophysiol; 2011 Sep; 106(3):1227-39. PubMed ID: 21653714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levetiracetam accelerates the onset of supply rate depression in synaptic vesicle trafficking.
    García-Pérez E; Mahfooz K; Covita J; Zandueta A; Wesseling JF
    Epilepsia; 2015 Apr; 56(4):535-45. PubMed ID: 25684406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levetiracetam has an activity-dependent effect on inhibitory transmission.
    Meehan AL; Yang X; Yuan LL; Rothman SM
    Epilepsia; 2012 Mar; 53(3):469-76. PubMed ID: 22292611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of levetiracetam on axon excitability and synaptic transmission at the crayfish neuromuscular junction.
    Alshuaib S; Mosaddeghi J; Lin JW
    Synapse; 2020 Aug; 74(8):e22154. PubMed ID: 32189403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam.
    Lynch BA; Lambeng N; Nocka K; Kensel-Hammes P; Bajjalieh SM; Matagne A; Fuks B
    Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9861-6. PubMed ID: 15210974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seletracetam enhances short term depression in vitro.
    Yang X; Meehan AL; Rothman SM; Dubinsky JM
    Epilepsy Res; 2015 Nov; 117():17-22. PubMed ID: 26320080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of abnormal synaptic transmission in hippocampal CA3 neurons of spontaneously epileptic rats (SERs) by levetiracetam.
    Hanaya R; Kiura Y; Serikawa T; Kurisu K; Arita K; Sasa M
    Brain Res Bull; 2011 Nov; 86(5-6):334-9. PubMed ID: 21968023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of levetiracetam on the high-voltage-activated L-type Ca²⁺ channels in hippocampal CA3 neurons of spontaneously epileptic rat (SER).
    Yan HD; Ishihara K; Seki T; Hanaya R; Kurisu K; Arita K; Serikawa T; Sasa M
    Brain Res Bull; 2013 Jan; 90():142-8. PubMed ID: 23107646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged exposure to levetiracetam reveals a presynaptic effect on neurotransmission.
    Yang XF; Weisenfeld A; Rothman SM
    Epilepsia; 2007 Oct; 48(10):1861-9. PubMed ID: 17521346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue-specific dynamin-1 deletion at the calyx of Held decreases short-term depression through a mechanism distinct from vesicle resupply.
    Mahapatra S; Fan F; Lou X
    Proc Natl Acad Sci U S A; 2016 May; 113(22):E3150-8. PubMed ID: 27185948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further evidence for a differential interaction of brivaracetam and levetiracetam with the synaptic vesicle 2A protein.
    Wood MD; Sands ZA; Vandenplas C; Gillard M
    Epilepsia; 2018 Sep; 59(9):e147-e151. PubMed ID: 30144048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levetiracetam inhibits neurotransmitter release associated with CICR.
    Fukuyama K; Tanahashi S; Nakagawa M; Yamamura S; Motomura E; Shiroyama T; Tanii H; Okada M
    Neurosci Lett; 2012 Jun; 518(2):69-74. PubMed ID: 22484014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of levetiracetam on extracellular amino acid levels in the dorsal hippocampus of rats with temporal lobe epilepsy.
    Pichardo Macías LA; Ramírez Mendiola BA; Contreras García IJ; Zamudio Hernández SR; Chávez Pacheco JL; Sánchez Huerta KB; Mendoza Torreblanca JG
    Epilepsy Res; 2018 Feb; 140():111-119. PubMed ID: 29331845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Favorable adverse effect profile of brivaracetam vs levetiracetam in a preclinical model.
    Sanon NT; Gagné J; Wolf DC; Aboulamer S; Bosoi CM; Simard A; Messiet E; Desgent S; Carmant L
    Epilepsy Behav; 2018 Feb; 79():117-125. PubMed ID: 29287214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychopharmacology of anticonvulsants: levetiracetam as a synaptic vesicle protein modulator.
    Stahl SM
    J Clin Psychiatry; 2004 Sep; 65(9):1162-3. PubMed ID: 15367040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The synaptic vesicle glycoprotein 2A ligand levetiracetam inhibits presynaptic Ca2+ channels through an intracellular pathway.
    Vogl C; Mochida S; Wolff C; Whalley BJ; Stephens GJ
    Mol Pharmacol; 2012 Aug; 82(2):199-208. PubMed ID: 22554805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levetiracetam as an antiepileptic, neuroprotective, and hyperalgesic drug.
    Cortes-Altamirano JL; Olmos-Hernández A; Bonilla-Jaime H; Bandala C; González-Maciel A; Alfaro-Rodríguez A
    Neurol India; 2016; 64(6):1266-1275. PubMed ID: 27841198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of levetiracetam on astroglial release of kynurenine-pathway metabolites.
    Fukuyama K; Okada M
    Br J Pharmacol; 2018 Nov; 175(22):4253-4265. PubMed ID: 30153331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.